6-160722344-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000301.5(PLG):c.1097-64A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.246 in 1,210,450 control chromosomes in the GnomAD database, including 41,226 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.21 ( 4001 hom., cov: 32)
Exomes 𝑓: 0.25 ( 37225 hom. )
Consequence
PLG
NM_000301.5 intron
NM_000301.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0120
Publications
14 publications found
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
- hypoplasminogenemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- angioedema, hereditary, 4Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-160722344-A-G is Benign according to our data. Variant chr6-160722344-A-G is described in ClinVar as Benign. ClinVar VariationId is 1258345.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PLG | ENST00000308192.14 | c.1097-64A>G | intron_variant | Intron 9 of 18 | 1 | NM_000301.5 | ENSP00000308938.9 | |||
| PLG | ENST00000418964.2 | c.1148-64A>G | intron_variant | Intron 9 of 18 | 4 | ENSP00000389424.2 | ||||
| PLG | ENST00000297289.9 | c.50-64A>G | intron_variant | Intron 1 of 10 | 5 | ENSP00000516619.1 | ||||
| PLG | ENST00000706906.1 | n.1097-64A>G | intron_variant | Intron 9 of 18 | ENSP00000516618.1 |
Frequencies
GnomAD3 genomes AF: 0.211 AC: 32094AN: 151968Hom.: 4005 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
32094
AN:
151968
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.251 AC: 265523AN: 1058364Hom.: 37225 AF XY: 0.248 AC XY: 135280AN XY: 545312 show subpopulations
GnomAD4 exome
AF:
AC:
265523
AN:
1058364
Hom.:
AF XY:
AC XY:
135280
AN XY:
545312
show subpopulations
African (AFR)
AF:
AC:
2505
AN:
25728
American (AMR)
AF:
AC:
5590
AN:
43828
Ashkenazi Jewish (ASJ)
AF:
AC:
6878
AN:
23658
East Asian (EAS)
AF:
AC:
20
AN:
37794
South Asian (SAS)
AF:
AC:
8355
AN:
78152
European-Finnish (FIN)
AF:
AC:
13837
AN:
52820
Middle Eastern (MID)
AF:
AC:
1268
AN:
4964
European-Non Finnish (NFE)
AF:
AC:
215760
AN:
744402
Other (OTH)
AF:
AC:
11310
AN:
47018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
9491
18981
28472
37962
47453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5492
10984
16476
21968
27460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.211 AC: 32085AN: 152086Hom.: 4001 Cov.: 32 AF XY: 0.207 AC XY: 15372AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
32085
AN:
152086
Hom.:
Cov.:
32
AF XY:
AC XY:
15372
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
4253
AN:
41480
American (AMR)
AF:
AC:
2996
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1059
AN:
3466
East Asian (EAS)
AF:
AC:
9
AN:
5180
South Asian (SAS)
AF:
AC:
495
AN:
4818
European-Finnish (FIN)
AF:
AC:
2769
AN:
10574
Middle Eastern (MID)
AF:
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19760
AN:
67962
Other (OTH)
AF:
AC:
476
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1295
2590
3885
5180
6475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
162
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.